Genetic stability of RSV-F expression and the restricted growth phenotype of a live attenuated PIV3 vectored RSV vaccine candidate (MEDI-534) following restrictive growth in human lung cells (Q39159542)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 April 2013

Language	Label	Description	Also known as
English	Genetic stability of RSV-F expression and the restricted growth phenotype of a live attenuated PIV3 vectored RSV vaccine candidate (MEDI-534) following restrictive growth in human lung cells	scientific article published on 24 April 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Genetic stability of RSV-F expression and the restricted growth phenotype of a live attenuated PIV3 vectored RSV vaccine candidate (MEDI-534) following restrictive growth in human lung cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

attenuated vaccine

1 reference

based on heuristic

inferred from title

author name string

Christine L Nelson

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Roderick S Tang

2

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Elizabeth A Stillman

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

language of work or name

0 references

publication date

24 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

3756-3762

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Challenges in developing a pediatric RSV vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.015

7 January 2021

Phase 1 study of the safety and immunogenicity of a live, attenuated respiratory syncytial virus and parainfluenza virus type 3 vaccine in seronegative children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.015

7 January 2021

Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.015

7 January 2021

Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3' proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.015

7 January 2021

Determinants of the host range restriction of replication of bovine parainfluenza virus type 3 in rhesus monkeys are polygenic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.015

7 January 2021

Evaluation of attenuation, immunogenicity and efficacy of a bovine parainfluenza virus type 3 (PIV-3) vaccine and a recombinant chimeric bovine/human PIV-3 vaccine vector in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.015

7 January 2021

Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.015

7 January 2021

Development of a PIV-vectored RSV vaccine: preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.015

7 January 2021

Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.015

7 January 2021

An S101P substitution in the putative cleavage motif of the human metapneumovirus fusion protein is a major determinant for trypsin-independent growth in vero cells and does not alter tissue tropism in hamsters

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.015

7 January 2021

Bovine parainfluenza virus type 3 (PIV3) expressing the respiratory syncytial virus (RSV) attachment and fusion proteins protects hamsters from challenge with human PIV3 and RSV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.015

7 January 2021

Nucleocapsid incorporation into parainfluenza virus is regulated by specific interaction with matrix protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.015

7 January 2021

Role of matrix and fusion proteins in budding of Sendai virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.015

7 January 2021

Polymerase slippage at vesicular stomatitis virus gene junctions to generate poly(A) is regulated by the upstream 3'-AUAC-5' tetranucleotide: implications for the mechanism of transcription termination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.015

7 January 2021

RNA sequences involved in transcriptional termination of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.015

7 January 2021

Identification of an upstream sequence element required for vesicular stomatitis virus mRNA transcription

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.015

7 January 2021

Variations in transcription termination signals of human respiratory syncytial virus clinical isolates affect gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.015

7 January 2021

Mechanisms of loss of foreign gene expression in recombinant vesicular stomatitis viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.015

7 January 2021

Adding genes to the RNA genome of vesicular stomatitis virus: positional effects on stability of expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.015

7 January 2021

Selection for gene junction sequences important for VSV transcription

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.015

7 January 2021

Identifiers

10.1016/J.VACCINE.2013.04.015

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39159542&oldid=1810865646"